CARIS.
software company in Canada
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
Earlier this month
One to three months ago
-
CARIS gained FDA approval for its MI Cancer Seek test and was subsequently listed on the Nasdaq stock exchange.Some support1 report
-
Blue Owl provided a $700 million platform-wide loan to Caris on August 8, 2026.Some support1 report
-
Analyst ratings for Caris Life Sciences were published via MarketBeat, and the company is listed on the Nasdaq exchange.Some support4 reports
-
CARIS announced new leadership appointments, naming Luke Power as CFO and David Dean Halbert as CEO.Some support2 reports
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around CARIS this week
News at the entities that move CARIS most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves CARIS
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves CARIS
-
Nasdaq StructuralA Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.Moves CARIS
-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves CARIS
-
Delta Air Lines StructuralDirector Michael Huerta disclosed the sale of company stock, while Bank of America raised its price target for Delta Air Lines.Moves CARIS
-
MarketBeat StructuralTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves CARIS
Connections
The 13 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
CARIS is formally listed and traded on the Nasdaq stock exchange.
-
Luke Power Structural
Luke Power serves as the Chief Financial Officer for CARIS.
-
SEC Structural
CARIS is formally regulated by the SEC, requiring the company to file transactions under SEC oversight.
-
Delta Air Lines Structural
Delta Air Lines is a lease counterparty for CARIS engines, establishing a supply chain dependency.
-
American Airlines Transactional
American Airlines relies on CARIS as a lease counterparty for engine supply.
-
FDA Structural
The FDA granted regulatory approval to CARIS for its MI Cancer Seek test.
-
David Dean Halbert Structural
David Dean Halbert serves as the Founder and CEO of CARIS.
-
Zippy Structural
CARIS holds a 15% financial interest in Zippy.
Show all 13 connections
-
Texas Shared context
CARIS is located and operates within the geographic and regulatory context of the state of Texas.
-
Securities and Exchange Commission Structural
The SEC has alleged that CARIS engaged in a cherry-picking scheme, indicating regulatory oversight.
-
MarketBeat Structural
MarketBeat serves as the publishing platform for analyst ratings concerning CARIS.
-
Irving Shared context
CARIS is located in the city of Irving.
-
Albemarle Corporation Transactional
CARIS engaged in block trades of Albemarle Corporation stock.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
4 events- CARIS gained FDA approval for its MI Cancer Seek test and was subsequently listed on the Nasdaq stock exchange.
- Blue Owl provided a $700 million platform-wide loan to Caris on August 8, 2026.
- Analyst ratings for Caris Life Sciences were published via MarketBeat, and the company is listed on the Nasdaq exchange.
- CARIS announced new leadership appointments, naming Luke Power as CFO and David Dean Halbert as CEO.